CVS Health (CVS) shares jumped intraday Tuesday after the healthcare company announced a new chief financial officer and said that it is on track to meet or surpass its full-year 2025 outlook.

Brian Newman will join the company on April 21 as the future successor of current CFO Tom Cowhey, who will become an adviser to Chief Executive David Joyner on May 12. Newman left United Parcel Service (UPS) as CFO in 2024.

CVS named Amy Compton-Phillips as chief medical officer, effective next month. She most recently served as chief physician executive of health care performance improvement firm Press Ganey.

"As I continue to build out my leadership team, I am confident that Brian and Amy will help us continue the momentum we have built over the past several months as we execute on our strategy to deliver better health care to the 185 million Americans we are privileged to serve," Joyner, who became CEO of CVS Health in October, said in a statement.

Shares of the company were up 5.8% in afternoon trade, taking year-to-date gains to about 50%.

The company said it anticipates reporting full-year results in line or above its guidance. CVS is scheduled to release its first-quarter financial report on May 1.

CVS in February guided for 2025 adjusted per-share earnings in the range of $5.75 to $6, an improvement from last year's $5.42. The consensus on FactSet is for non-GAAP EPS of $5.90.

"I am confident in our continued success and growth potential, and I look forward to putting my experience to work as we help our clients, customers, and colleagues succeed," said Newman.